Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
01/2008
01/29/2008US7323448 Antibacterial agents
01/29/2008CA2383298C New amino acids, their preparation process and pharmaceutical compositions that contain these amino acids
01/29/2008CA2142998C N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors
01/24/2008WO2008010567A1 Salt or solvate of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid
01/24/2008WO2008010566A1 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid
01/24/2008WO2008010481A1 Aminoindan derivative or salt thereof
01/24/2008US20080021215 Reacting 3-fluoro-4-morpholinyl aniline derivative with epichlorohydrin; converting chloromethyl oxazolidinone to aminomethyl oxazolidinone; carbonylation ; reacting with potassium phthalimide, hydrazine hydrate, and acetic anhydride; cyclization, carbamylation; antibacterial agent
01/24/2008US20080021214 Novel process for the preparation of linezolid and related compounds
01/24/2008US20080021213 Intermediates for oxazolidinone antibacterials; N-[3-Chloro-2-(R)-hydroxypropyl]-3-fluoro-4-morpholinyl aniline
01/24/2008US20080021038 Novel Piperidine/8-Azabicyclo [3.2.1.] Octan Derivatives As Modulators Of Chemokine Receptor Ccr5
01/24/2008US20080021012 3-[4-{6-Substituted Alkanoyl Pyridin-3-Yl}-3-Phenyl]-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones As Antibacterial Agents
01/23/2008EP1880720A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
01/23/2008EP1879895A1 Enzyme inhibitors
01/23/2008EP1879863A1 Amide resorcinol compounds
01/23/2008EP1711825A4 Conjugated small molecules
01/23/2008EP1567498B1 Mandelic acid derivatives
01/23/2008EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity
01/23/2008CN101108835A Method of manufacturing high purity hydrochloric acid sarafloxacin
01/23/2008CN100363332C Aromatic amino acid derivative and its prepn process and medicinal use
01/22/2008US7321027 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same
01/22/2008US7321001 carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer
01/22/2008US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
01/22/2008CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance
01/22/2008CA2374362C Urea derivatives as hiv aspartyl protease inhibitors
01/17/2008WO2008007780A1 Pentadienamide derivative
01/17/2008WO2008007670A1 Fluoroboron compound, aminomethylating agent for aromatic ring comprising the compound, and process for production of compound having aminomethyl-aromatic ring using the aminomethylating agent
01/17/2008WO2008006754A1 Method for producing an amine
01/17/2008WO2008006752A1 Method for producing an amine
01/17/2008WO2008006750A1 Method for producing an amine
01/17/2008WO2008006749A1 Method for producing an amine
01/17/2008WO2008006748A1 Method for producing an amine
01/17/2008WO2008006276A1 THE SMALL MOLECULE INHIBITOR WHICH CAN INHIBIT THE AβPOLYPEPTIDE FIBROSIS OF ALZHEIMER'S DISEASE, THEIR PREPAREATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
01/17/2008WO2007137098A3 Sulfonyl-substituted bicyclic compounds as modulators of ppar
01/17/2008US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
01/17/2008US20080015190 Inhibitors of Histone Deacetylase
01/17/2008US20080015182 Potent PARP Inhibitors
01/17/2008US20080015180 Methods and compositions for treating amyloid-related diseases
01/17/2008US20080015172 Caspase inhibitors and uses thereof
01/17/2008US20080015169 Amino-methyl substituted tetracycline compounds
01/17/2008CA2658097A1 Pentadienamide derivatives
01/16/2008EP1877392A1 Method for producing an amine
01/16/2008EP1877367A1 Acetylene derivatives
01/16/2008EP1755593B1 Naphthalene derivatives useful as histamine-3-receptor ligands
01/16/2008EP1687288B1 Substituted aryl cycloalkanol derivatives and methods of their use
01/16/2008EP1644320B1 Indane derivates as muscarinic receptor agonists
01/16/2008EP1458684B1 Therapeutic heterocycles as bradykinin b2 receptor antagonists
01/16/2008EP1122242B1 Cyanophenyl derivatives
01/16/2008CN101107236A Cyclohexylamides as dopamine D3, D2 and 5HT1A antagonists
01/16/2008CN101107222A Substituted aminomethylene sulphonamides, production and use thereof as medicaments
01/16/2008CN101104609A Solanesyl polyamine derivative, preparation and application thereof
01/16/2008CN101104608A Solanesol derivative, preparation and application thereof
01/16/2008CN101104598A Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives
01/15/2008US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists
01/15/2008US7319099 Benzoyl-piperazine derivatives
01/15/2008US7319097 Treatment of type II diabetes with benzenesulfonamide substituted with an N-heterocycle: N-[2-amino-5-(1,4-diazepan-1-yl)phenyl]benzenesulfonamide, N-[4-amino-5-(piperazinyl)phenyl]benzenesulfonamide, 3-amino-4-(5-methyl-2,5-diaza-bicyclo[2.2.1]hept-2-yl)-N-phenyl-benzenesulfonamide hydrochloride
01/15/2008US7319084 An addition polymerization catalyst of a cationic transition metal complex of a neutral bidentate ligand including a pyrole ring and an anion or nickelbis(1,5-cyclooctadiene), tri(pentafluorophenyl)borane and the neutral bidentate ligand; heat resistance; stability; steric hinderance for process control
01/10/2008WO2008005954A2 Tryphostin-analogs for the treatment of cell proliferative diseases
01/10/2008WO2008005846A2 Methods, mixtures, kits and compositions pertaining to analyte determination
01/10/2008WO2008003141A1 Therapeutic compounds
01/10/2008US20080009521 Aryl Piperidine Amides
01/10/2008US20080009504 enzyme inhibitors of glucan synthase;1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-3-(acetyloxy)-2-[(2S)-2-amino-2,3-dimethylbutyloxy]-8-[(1R)-1,2-dimethyl propyl]-1,6a,8,10a-tetramethyl-6-oxo-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid
01/10/2008US20080009490 pyrazino[1,2-c]pyrimidine derivatives; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(4-Fluorobenzyl)-9-hydroxy-7-[(1R,2S)-2-phenylcyclopropyl]-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,6,8(7H)-trione
01/10/2008US20080009489 Androgen receptor modulators and method of treating disease using the same
01/10/2008US20080008811 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
01/10/2008US20080008810 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
01/10/2008US20080008682 Agonists; Treatment of Hepatitis C virus; combination with other drugs; phosphonate derivatives of purine or thiazolo(4,5-d)pyrimidine rings
01/10/2008CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity
01/10/2008CA2656295A1 Methods, mixtures, kits and compositions pertaining to analyte determination
01/09/2008EP1875903A1 Tuberculosis treatment using pleuromutilin derivatives
01/09/2008EP1874748A1 2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators
01/09/2008EP1874747A1 Histamine h3-recept0r ligands and their therapeutic application
01/09/2008EP1874746A2 Novel histamine h3-receptor ligands and their therapeutic applications
01/09/2008EP1307237B9 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
01/09/2008CN101103018A Compounds for the treatment of CNS and amyloid associated diseases
01/09/2008CN101103009A Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device
01/09/2008CN101100462A Synthesis method for levorotatory citirizine dihydrochloride
01/09/2008CN101100416A Small molecule inhibitor for preventing Alzheimer's disease Abeta polypeptide from fiberizing and its preparation method, pharmaceutical composition and application
01/09/2008CN100360510C Process for producing oxycarbonyl-substituted piperazine derivative
01/08/2008US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents
01/08/2008CA2334298C Neuropeptide y5 receptor antagonists
01/08/2008CA2172513C Aminocyclohexylesters and uses thereof
01/03/2008WO2008002820A2 Substituted benzyl amine compounds
01/03/2008WO2008002818A1 Substituted aminomethyl benzamide compounds
01/03/2008WO2008002817A1 Butyl and butynyl benzyl amine compounds
01/03/2008WO2008002816A1 Substituted benzamide modulators of the histamine h3 receptor
01/03/2008WO2008002583A1 Glycine transporter-1 inhibitors
01/03/2008WO2008001160A1 Melanin concentrating hormone antagonists
01/03/2008WO2008000969A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same
01/03/2008WO2008000729A1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
01/03/2008US20080004443 Sulfonated polyaryletherketone-block-polyethersulfone copolymers
01/03/2008US20080004315 Guanidine Derivatives and Therapeutic Uses Thereof
01/03/2008US20080004265 HIV Integrase Inhibitors
01/03/2008US20080004258 such as [2-(3,4-Dichloro-phenoxy)-5-(4-morpholin-4-yl-but-1-ynyl)-benzyl]-methyl-amine, used as H3 receptor and/or serotonin transporter modulators useful in the treatment of cognitive, sleep and psychological disorders
01/03/2008US20080004256 Amidinophenylalanine Derivatives as Thrombin Inhibitors
01/03/2008CA2656089A1 Substituted benzyl amine compounds
01/03/2008CA2656083A1 Substituted aminomethyl benzamide compounds
01/03/2008CA2656075A1 Butyl and butynyl benzyl amine compounds
01/03/2008CA2656072A1 Substituted benzamide modulators of the histamine h3 receptor
01/03/2008CA2655540A1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
01/03/2008CA2655159A1 Glycine transporter-1 inhibitors
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 341